Inhibition of cardiac hypertrophy by triflusal (4-trifluoromethyl derivative of salicylate) and its active metabolite

Molecular Pharmacology

Volumn 69, Issue 4, 2006, Pages 1174-1181

  Planavila, Anna ^a   Rodríguez Calvo, Ricardo ^a   De Arriba, Alberto Fernández ^b   Śanchez, Rosa M ^a   Laguna, Juan C ^a   Merlos, Manuel ^b   V́azquez Carrera, Manuel ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Laboratorio Uriach   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXY 4 (TRIFLUOROMETHYL)BENZOIC ACID; ACETYLLEUCYLLEUCYLNORLEUCINAL; ACETYLSALICYLIC ACID; ALPHA ACTININ; ATRIAL NATRIURETIC FACTOR; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; HETERODIMER; I KAPPA B KINASE ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUCINE; MESSENGER RNA; PHENYLEPHRINE; PROTEIN P50; PROTEINASE INHIBITOR; SALICYLIC ACID DERIVATIVE; SYNAPTOTAGMIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN SYNTHESIS; RAT; SARCOPLASM;

ANIMALS; ASPIRIN; BASE SEQUENCE; CARDIOMEGALY; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; IMMUNOPRECIPITATION; MALE; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; RNA PROCESSING, POST-TRANSCRIPTIONAL; SALICYLATES; SIGNAL TRANSDUCTION;

EID: 33645109885     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.016345     Document Type: Article

References (35)

1. Acarin L, Gonzalez B, and Castellano B (2000) Oral administration of the anti-inflammatory substance triflusal results in the downregulation of constitutive transcription factor NF-kappa B in the postnatal rat brain. Neurosci Lett 288:41-44.
2. Bayon Y, Alonso A, and Crespo MS (1999) 4-Trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy-4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor kappa B activation. Br J Pharmacol 126:1359-1366.
3. Cabrero A, Alegret M, Sanchez RM, Adzet T, Laguna JC, and Carrera MV (2002) Increased reactive oxygen species production down-regulates peroxisome proliferator-activated alpha pathway in C2C12 skeletal muscle cells. J Biol Chem 277:10100-10107.
4. Cabrero A, Alegret M, Sanchez RM, Adzet T, Laguna JC, and Vazquez M (2001) Bezafibrate reduces mRNA levels of adipocyte markers and increases fatty acid oxidation in primary culture of adipocytes. Diabetes 50:1883-1890.
5. de Arriba AF, Cavalcanti F, Miralles A, Bayon Y, Alonso A, Merlos M, Garcia-Rafanell J, and Forn J (1999) Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid. Mol Pharmacol 55:753-760.
6. Ferrari E, Reboldi G, Marenco P, D'Angelo L, Crema F, Ambrosoli L, Poli A, Girardello R, and Lowenthal DT (1996) Pharmacokinetic study of triflusal in elderly subjects after single and repeated oral administration. Am J Ther 3:630-636.
7. Ferreira SH, Moncada S, and Vane JR (1971) Indomethacin and aspirin abolish prostaglandin release from spleen. Nat New Biol 231:237-239.
8. + lymphocytes. Nature (Lond) 426:853-857.
9. Grabellus F, Levkau B, Sokoll A, Welp H, Schmid C, Deng MC, Takeda A, Breithardt G, and Baba HA (2002) Reversible activation of nuclear factor-kappa B in human end-stage heart failure after left ventricular mechanical support. Cardiovasc Res 53:124-130.
10. Grilli M, Pizzi M, Memo M, and Spano P (1996) Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappa B activation. Science (Wash DC) 274:1383-1385.
11. Grisham MB, Palombella VJ, Elliott PJ, Conner EM, Brand S, Wong HL, Pien C, Mazzola LM, Destree A, Parent L, et al. (1999) Inhibition of NF-kappa B activation in vitro and in vivo: role of 26S proteasome. Methods Enzymol 300:345-363.
12. Gupta S, Purcell NH, Lin A, and Sen S (2002) Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy. J Cell Biol 159:1019-1028.
13. Hernandez M, de Arriba AF, Merlos M, Fuentes L, Crespo MS, and Nieto ML (2001) Effect of 4-trifluoromethyl derivatives of salicylate on nuclear factor kappa B-dependent transcription in human astrocytoma cells. Br J Pharmacol 132:547-555.
14. Higuchi Y, Otsu K, Nishida K, Hirotani S, Nakayama H, Yamaguchi O, Matsumura Y, Ueno H, Tada M, and Hori M (2002) Involvement of reactive oxygen species-mediated NF-kappa B activation in TNF-alpha-induced cardiomyocyte hypertrophy. J Mol Cell Cardiol 34:233-240.
15. Hirotani S, Otsu K, Nishida K, Higuchi Y, Morita T, Nakayama H, Yamaguchi O, Mano T, Matsumura Y, Ueno H, et al. (2002) Involvement of nuclear factor-kappa B and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation 105:509-515.
16. Hunter JJ and Chien KR (1999) Mechanisms of disease - signaling pathways for cardiac hypertrophy and failure. N Engl J Med 341:1276-1283.
17. Jorda EG, Verdaguer E, Canudas AM, Jimenez A, Bruna A, Caelles C, Bravo R, Escubedo E, Pubill D, Camarasa J, et al. (2003) Neuroprotective action of flavopiridol, a cyclin-dependent kinase inhibitor, in colchicine-induced apoptosis. Neuropharmacology 45:672-683.
18. Karin M and Ben-Neriah Y (2000) Phosphorylation meets ubiquitination: the control of NF-kappa B activity. Annu Rev Immunol 18:621-663.
19. 2+ ATPase and decreasing phospholamban expression. J Mol Cell Cardiol 26:1145-1154.
20. Kopp E and Ghosh S (1994) Inhibition of NF-kappa-B by sodium-salicylate and aspirin. Science (Wash DC) 265:956-959.
21. Lanas A, Serrano P, Bajador E, Fuentes J, and Sainz R (2003) Risk of upper gastrointestinal bleeding associated with non-aspirin cardiovascular drugs, analgesics and nonsteroidal anti-inflammatory drugs. Eur J Gastroenterol Hepatol 15:173-178.
22. Levy D, Garrison RJ, Savage DD, Kannel WB, and Castelli WP (1990) Prognostic implications of echocardiographically determined left-ventricular mass in the Framingham-Heart-Study. N Engl J Med 322:1561-1566.
23. Lorell BH and Carabello BA (2000) Left ventricular hypertrophy - pathogenesis, detection and prognosis. Circulation 102:470-479.
24. Matias-Guiu J, Ferro JM, Alvarez-Sabin J, Torres F, Jimenez MD, Lago A, and Melo T (2003) Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial. Stroke 34:840-847.
25. McNeely W and Goa KL (1998) Triflusal. Drugs 55:823-833.
26. Nakamura K, Fushimi K, Kouchi H, Mihara K, Miyazaki M, Ohe T, and Namba M (1998) Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-α and angiotensin II. Circulation 98:794-799.
27. Oeth P and Mackman N (1995) Salicylates inhibit lipopolysaccharide- induced transcriptional activation of the tissue factor gene in human monocytic cells. Blood 86:4144-4152.
28. Pierce JW, Read MA, Ding H, Luscinskas FW, and Collins T (1996) Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression and neutrophil transmigration. J Immunol 156:3961-3969.
29. Purcell NH, Tang GL, Yu CF, Mercurio F, DiDonato JA, and Lin AN (2001) Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc Natl Acad Sci USA 98:6668-6673.
30. Stasiolek M, Gavrilyuk V, Sharp A, Horvath P, Selmaj K, and Feinstein DL (2000) Inhibitory and stimulatory effects of lactacystin on expression of nitric oxide synthase type 2 in brain glial cells: the role of IκB-β. J Biol Chem 275:24847-24856.
31. Tam WF, Lee LH, Davis L, and Sen R (2000) Cytoplasmic sequestration of Rel proteins by I kappa B alpha requires CRM1-dependent nuclear export. Mol Cell Biol 20:2269-2284.
32. Thaik CM, Calderone A, Takahashi N, and Colucci WS (1995) Interleukin-1-beta modulates the growth and phenotype of neonatal rat cardiac myocytes. J Clin Investig 96:1093-1099.
33. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231:232-235.
34. Wong SCY, Fukuchi M, Melnyk P, Rodger I, and Giaid A (1998) Induction of cyclooxygenase-2 and activation of nuclear factor-kappa B in myocardium of patients with congestive heart failure. Circulation 98:100-103.
35. Yamamoto K, Ohki R, Lee RT, Ikeda U, and Shimada K (2001) Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes. Circulation 104:1670-1675.